Related Experiment Video
Updated: Jan 13, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Epidemiology of Pediatric Tuberculosis in the Western Cape: A Population-Based Study (2017-2023)
Lauren R Brown1, Mariette Smith2,3, Cari van Schalkwyk1
1South African Centre for Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.
Insights
Pediatric tuberculosis (TB) disproportionately affects young children in South Africa's Western Cape, with significant geographic disparities and care gaps. Addressing local drivers and improving data systems are crucial for better TB control in children.
Area of Science:
- Public Health
- Epidemiology
- Infectious Diseases
Background:
- Pediatric tuberculosis (TB) is a significant public health issue in high-burden areas like South Africa's Western Cape.
- Geographic variations in TB burden among children and young adolescents require detailed analysis.
Purpose of the Study:
- To analyze geographic differences in pediatric TB burden in the Western Cape.
- To describe temporal trends in pediatric TB.
- To quantify gaps within the pediatric TB care cascade.
Main Methods:
- A population-based descriptive study using data from the Provincial Health Data Centre (PHDC) from 2017 to 2023.
- Analysis included age stratification, HIV and drug resistance status, microbiological testing, diagnosis location, and treatment outcomes.
- Reporting gaps were assessed by comparing PHDC data with national notifications; incidence rates were calculated using population estimates.
Main Results:
- In 2023, TB incidence was highest in children aged 0-4 years (722.4/100,000), who constituted 68.9% of pediatric TB cases.
- The Cape Winelands district showed double the incidence in 0-4 year olds compared to adults and was 2-4 times higher than other districts.
- Significant underreporting (20.6%) and initial loss to follow-up (17.9%) were observed between 2017 and 2023.
Conclusions:
- Geographic variations in pediatric TB burden necessitate targeted interventions addressing local drivers.
- Gaps in the pediatric TB care cascade, including underreporting and loss to follow-up, remain critical concerns.
- Enhanced integrated data systems are vital for improving TB surveillance, health system planning, and patient outcomes in children.
Background:
Pediatric tuberculosis (TB) remains a major public health concern in high-burden settings like the Western Cape (WC), South Africa. We analyzed geographic differences in TB burden among children and young adolescents, described temporal trends, and quantified gaps in the TB care cascade.
Methods:
We conducted a population-based descriptive study of pediatric TB episodes recorded in the Provincial Health Data Centre (PHDC) from 2017 to 2023, stratified by 5-year age groups. We assessed HIV status, drug resistance status, microbiological testing, disease classification, place of diagnosis, and TB treatment outcomes. Reporting gaps were estimated by comparing PHDC-recorded episodes with national notifications. Incidence rates of diagnosis were calculated using mid-year population estimates.
Results:
In 2023, TB incidence rates of diagnosis in the WC were 722.4, 189.1, and 171.2 per 100 000 population for ages 0 to 4, 5 to 9, and 10 to 14 years. Children aged 0 to 4 years accounted for 68.9% of pediatric TB episodes. In the Cape Winelands district in 2023, TB incidence of diagnosis among 0- to 4-year-olds was double that of adults in the district and 2 to 4 times higher than 0- to 4-year-olds in other districts. We found high levels of underreporting (20.6%) and initial loss to follow-up (17.9%) among children and young adolescents diagnosed with TB between 2017 and 2023.
Conclusions:
Our findings highlight geographic variation in pediatric TB burden in the WC, emphasizing the need to address local drivers to inform targeted interventions. Gaps in the pediatric TB care cascade remain major concerns. Strengthening integrated data systems beyond TB treatment registers could improve surveillance, health system planning, and patient outcomes.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

